Fertility in female patients with thalassemia - PubMed (original) (raw)
. 1998:11 Suppl 3:935-43.
Affiliations
- PMID: 10091168
Fertility in female patients with thalassemia
N Skordis et al. J Pediatr Endocrinol Metab. 1998.
Abstract
With recent therapeutic advances, thalassemic patients can now reach adulthood and attain reproductive capacity. Endocrine complications due to hemosiderosis and especially hypogonatotropic hypogonadism, which present either with sexual infantilism and primary amenorrhea or with secondary amenorrhea, are common in thalassemic women. The aim of this study was to estimate the frequency of fertility among our female thalassemic patients. Our population included 50 married women with thalassemia major (TM) and 12 with thalassemia intermedia (TI) who are regularly followed in our thalassemic centers. Of the 50 patients with TM, 7 had primary amenorrhea (PA), 9 had secondary amenorrhea (SA), and 34 had normal menstrual function (NM), as did all the patients with TI. Overall we had 62 women who were able to achieve 90 pregnancies and give birth to 87 healthy babies. Most of our patients became pregnant around the age of 25 years. Associated endocrine complications were rare except in the group of patients with PA, as expected. In all patients with PA and SA, the 17 pregnancies were induced (intercourse 10, insemination 3, IVF 4). In the patients with NM and TI, 66 pregnancies were achieved spontaneously and 7 following induction (insemination 3, IVF 4). There were four twin and one triple pregnancies, which all resulted in premature deliveries. Among the seven couples in which both partners had thalassemia major, sperm donation was used in 5 cases, ovum donation in one case, and one pregnancy was achieved spontaneously. These 90 pregnancies resulted in 69 full-term, 12 pre-term, 7 abortions and 2 stillbirths. No severe obstetric complication was observed except for two patients with preeclampsia. One patient with PA who carried the triple pregnancy developed severe cardiac failure, which was successfully treated. Transfusion requirements were increased during pregnancy. Discontinuation of desferrioxamine resulted in elevation of ferritin levels during the second and third trimesters of pregnancy and after delivery. Nine patients who were examined with cardiac echo had a transient increase of ESD and EDD during pregnancy, with return to normal after delivery. Labor was performed by Caesarian section in 26 births (26%) out of the 81 successful pregnancies. These collected data represent the largest number of pregnancies in thalassemic females reported so far and are clearly encouraging for the ultimate improvement of the quality of life in thalassemic patients.
Similar articles
- Fertility in thalassemia: the Greek experience.
Karagiorga-Lagana M. Karagiorga-Lagana M. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:945-51. J Pediatr Endocrinol Metab. 1998. PMID: 10091169 - Fertility and pregnancy in thalassemia major.
Tuck SM. Tuck SM. Ann N Y Acad Sci. 2005;1054:300-7. doi: 10.1196/annals.1345.062. Ann N Y Acad Sci. 2005. PMID: 16339678 Review. - Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants.
Ansari S, Azarkeivan A, Tabaroki A. Ansari S, et al. Pediatr Hematol Oncol. 2006 Jan-Feb;23(1):33-7. doi: 10.1080/08880010500313306. Pediatr Hematol Oncol. 2006. PMID: 16326410 - Outcome and management of pregnancy in women with thalassaemia in Cyprus.
Toumba M, Kanaris C, Simamonian K, Skordis N. Toumba M, et al. East Mediterr Health J. 2008 May-Jun;14(3):628-35. East Mediterr Health J. 2008. PMID: 18720627 - Pregnancies in women with Turner's syndrome.
Hovatta O. Hovatta O. Ann Med. 1999 Apr;31(2):106-10. Ann Med. 1999. PMID: 10344582 Review.
Cited by
- Beta-thalassaemia intermedia: evaluation of endocrine and bone complications.
Baldini M, Marcon A, Cassin R, Ulivieri FM, Spinelli D, Cappellini MD, Graziadei G. Baldini M, et al. Biomed Res Int. 2014;2014:174581. doi: 10.1155/2014/174581. Epub 2014 Jul 7. Biomed Res Int. 2014. PMID: 25110660 Free PMC article. - Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines.
De Sanctis V, Soliman AT, Elsedfy H, Skordis N, Kattamis C, Angastiniotis M, Karimi M, Yassin MA, El Awwa A, Stoeva I, Raiola G, Galati MC, Bedair EM, Fiscina B, El Kholy M. De Sanctis V, et al. Indian J Endocrinol Metab. 2013 Jan;17(1):8-18. doi: 10.4103/2230-8210.107808. Indian J Endocrinol Metab. 2013. PMID: 23776848 Free PMC article. - The reproduction in women affected by cooley disease.
Pafumi C, Leanza V, Coco L, Vizzini S, Ciotta L, Messina A, Leanza G, Zarbo G, D'Agati A, Palumbo MA, Iemmola A, Gulino FA, Teodoro MC, Attard M, Plesca AC, Soares C, Kouloubis N, Chammas M. Pafumi C, et al. Hematol Rep. 2011 Jan 13;3(1):e4. doi: 10.4081/hr.2011.e4. Epub 2011 Mar 23. Hematol Rep. 2011. PMID: 22184526 Free PMC article. - The pregnancy outcome in patients with minor β-thalassemia.
Amooee S, Samsami A, Jahanbakhsh J, Karimi M. Amooee S, et al. Iran J Reprod Med. 2011 Winter;9(1):9-14. Iran J Reprod Med. 2011. PMID: 25356075 Free PMC article. - Pregnant women affected by thalassemia major: a controlled study of traits and personality.
Messina G, Colombo E, Cassinerio E, Cesaretti C, Marcon A, Zanaboni L, Baldini M, Cappellini MD. Messina G, et al. J Res Med Sci. 2010 Mar;15(2):100-6. J Res Med Sci. 2010. PMID: 21526066 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous